Polyclonal Rabbit anti‑Human Apolipoprotein A‑V Antibody (Biotin, aa167‑335, WB) LS‑C686624
Polyclonal Rabbit anti‑Human Apolipoprotein A‑V Antibody (Biotin, aa167‑335, WB) LS‑C686624
Antibody:
Apolipoprotein A-V Rabbit anti-Human Polyclonal (aa167-335) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
Apolipoprotein A-V Rabbit anti-Human Polyclonal (aa167-335) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Apolipoprotein A-V antibody LS-C686624 is a biotin-conjugated rabbit polyclonal antibody to human Apolipoprotein A-V (aa167-335). Validated for WB.
Target
Human Apolipoprotein A-V
Synonyms
APOA5 | Apo-AV | APOAV | Apolipoprotein A5 | Apo-A5 | Apolipoprotein A-V | RAP3 | ApoA-V
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant APOA5 (Asp167-Lys335) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against APOA5.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Species:
Mouse
Applications:
Western blot
Species:
Human, Monkey, Mouse
Applications:
Western blot
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Human
Range:
1.25-80 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024